共 24 条
[2]
Buse DC, 2009, MAYO CLIN PROC, V84, P422, DOI 10.1016/S0025-6196(11)60561-2
[4]
D'Amico Domenico, 2008, Neuropsychiatr Dis Treat, V4, P1155
[5]
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
[J].
HEADACHE,
2010, 50 (06)
:921-936
[8]
Effect of preventive (β blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial
[J].
BMJ-BRITISH MEDICAL JOURNAL,
2010, 341
:769
[9]
Development and validation of the Migraine-Specific Quality of Life Questionnaire
[J].
HEADACHE,
1998, 38 (04)
:295-302
[10]
Adherence to Acute Migraine Medication: What Does It Mean, Why Does It Matter?
[J].
HEADACHE,
2010, 50 (01)
:117-129